OAOFY yields 20.94% · JNJ yields 2.13%● Live data
📍 OAOFY pulled ahead of the other in Year 1
Combined, OAOFY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OAOFY + JNJ for your $10,000?
PJSC Tatneft, together with its subsidiaries, engages in exploration, development, and production of crude oil primarily in Russia. The company operates through Exploration and Production, Refining and Marketing, Petrochemical Products, and Banking segments. It holds interests in oil and gas fields located in Tatarstan in Russia. The company is also involved in the refining and marketing crude oil; the purchase and sale of crude oil and refined products from third parties; and retailing activities. In addition, it produces and sells tires; and manufactures and sells equipment, as well as provides engineering, procurement, and construction services for oil, gas, and petrochemical projects. Further, the company sells oilfield equipment, and auxiliary petrochemical related services and materials. Additionally, it is involved in the banking activities. The company was founded in 1950 and is headquartered in Almetyevsk, Russia.
Full OAOFY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.